Singer Bret Michaels of Poison Hospitalized Reportedly Following Adverse Reaction to Covid-19 Treatment — Forced to Cancel Nashville Show

Bret Michaels, the vocalist of Poison, had to cancel a concert on his Stadium Tour after being hospitalized on Thursday due to an adverse reaction to Covid-19 medication, sources told TMZ.

“Sources connected to Bret tell TMZ … he may have had a bad reaction to medication that is related to COVID … medication that triggered a reaction as a result of his diabetes,” the news outlet reported.

It is still unclear what Covid medication he took.

The band is currently on tour with Def Leppard, Motley Crue, and Joan Jett. According to audience witnesses, members of Poison appeared on stage and informed the fans that Bret had to go to the hospital due to an adverse reaction.

The remaining members of the band stated that they would be unable to perform their set.

Watch the band’s announcement below:

The 59-year-old singer confirmed the incident and apologized to his fans after he was unable to perform at Nissan Stadium.

“To the incredible fans in Nashville, thank you for all your well wishes!! I was truly fired up to get on stage in Music City and perform, but due to an unforeseen medical complication and following hospitalization, it was not possible,” a statement on his Instagram read.

“I send my deepest apologies for being unable to rock the stage tonight!!! I’m working on being back 100% very soon and hope you rocked hard with my friends Motley/Leppard/Joan and the Classless Act!!!,” he added.

Although it is unclear how long Michaels will be out, the tour continues with shows in Florida on Saturday and Mississippi on Sunday, according to TMZ.

Photo of author
Jim Hᴏft is the founder and editor of The Gateway Pundit, one of the top conservative news outlets in America. Jim was awarded the Reed Irvine Accuracy in Media Award in 2013 and is the proud recipient of the Breitbart Award for Excellence in Online Journalism from the Americans for Prosperity Foundation in May 2016.

You can email Jim Hoft here, and read more of Jim Hoft's articles here.


Thanks for sharing!